/4577.T
4577.T Stock - Daito Pharmaceutical Co.,Ltd.
Healthcare|Drug Manufacturers - Specialty & GenericJPX
$1357.00-0.44%
$6.00 (-0.44%) • Dec 24
76
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.87
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1492.70
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 4577.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1343.43 – $1370.57
TARGET (TP)$1560.55
STOP LOSS$1248.44
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.25
52W High$1382.00
52W Low$970.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $50.64B | $46.90B | $45.10B | $43.46B | $48.71B |
| Gross Profit | $8.64B | $9.84B | $10.33B | $11.46B | $10.79B |
| Gross Margin | 17.1% | 21.0% | 22.9% | 26.4% | 22.2% |
| Operating Income | $2.62B | $3.89B | $5.21B | $6.55B | $5.91B |
| Net Income | $1.91B | $3.29B | $3.60B | $4.67B | $4.25B |
| Net Margin | 3.8% | 7.0% | 8.0% | 10.7% | 8.7% |
| EPS | $62.72 | $105.00 | $113.82 | $152.45 | $141.36 |
Company Overview
Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
4577.TBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$23.24
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Oct 10, 2025 | — | $23.24 | — | — |
Q3 2025 | Jul 11, 2025 | — | $22.71 | — | — |
Q2 2025 | Apr 14, 2025 | — | $20.30 | — | — |
Q1 2025 | Jan 10, 2025 | — | $18.96 | — | — |
Q4 2024 | Oct 11, 2024 | — | $40.41 | — | — |
Q3 2024 | Jul 12, 2024 | — | $61.83 | — | — |
Q2 2024 | Apr 12, 2024 | — | $50.14 | — | — |
Q1 2024 | Jan 12, 2024 | — | $54.99 | — | — |
Q4 2023 | Oct 12, 2023 | — | $43.22 | — | — |
Q3 2023 | Jul 14, 2023 | — | $65.43 | — | — |
Q2 2023 | Apr 13, 2023 | — | $62.51 | — | — |
Q1 2023 | Jan 13, 2023 | — | $56.74 | — | — |
Q4 2022 | Oct 13, 2022 | — | $65.71 | — | — |
Q3 2022 | Jul 14, 2022 | — | $48.56 | — | — |
Q2 2022 | Apr 14, 2022 | — | $85.93 | — | — |
Q1 2022 | Jan 14, 2022 | — | $69.11 | — | — |
Q4 2021 | Oct 13, 2021 | — | $133.09 | — | — |
Q3 2021 | Jul 14, 2021 | — | $39.85 | — | — |
Q2 2021 | Apr 14, 2021 | — | $94.73 | — | — |
Q1 2021 | Jan 14, 2021 | — | $80.22 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 4577.T
What is 4577.T's current stock price?
Daito Pharmaceutical Co.,Ltd. (4577.T) is currently trading at $1357.00 per share. The stock has moved -0.44% today.
What is the analyst price target for 4577.T?
No analyst price targets are currently available for this stock.
What sector is Daito Pharmaceutical Co.,Ltd. in?
Daito Pharmaceutical Co.,Ltd. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the JPX exchange.
What is 4577.T's market cap?
Daito Pharmaceutical Co.,Ltd. has a market capitalization of $40.69 billion, making it a large-cap company.
Does 4577.T pay dividends?
No, Daito Pharmaceutical Co.,Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector3183.T
WIN-Partners Co., Ltd.
$1314.00
Mkt Cap: $36.5B
4548.T
Seikagaku Corporation
$701.00
Mkt Cap: $38.3B
4554.T
Fuji Pharma Co., Ltd.
$1870.00
Mkt Cap: $45.6B
4595.T
Mizuho Medy Co.,Ltd.
$1748.00
Mkt Cap: $33.3B
5592.T
Kusurinomadoguchi, Inc.
$2636.00
Mkt Cap: $29.6B
6062.T
Charm Care Corporation
$1295.00
Mkt Cap: $42.3B
7679.T
YAKUODO HOLDINGS Co., Ltd.
$2186.00
Mkt Cap: $42.8B
7749.T
Medikit Co.,Ltd.
$2960.00
Mkt Cap: $43.3B
7777.T
3-D Matrix, Ltd.
$338.00
Mkt Cap: $37.4B
9273.T
Koa Shoji Holdings Co.,Ltd.
$831.00
Mkt Cap: $35.0B
Explore stocks similar to 4577.T for comparison